Edition:
United Kingdom

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

1.79USD
18 May 2018
Change (% chg)

$0.07 (+4.07%)
Prev Close
$1.72
Open
$1.72
Day's High
$1.81
Day's Low
$1.71
Volume
14,550
Avg. Vol
30,922
52-wk High
$3.69
52-wk Low
$1.32

Chart for

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $30.56
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  VICL.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -1.04 -- --
ROI: -27.79 1.57 14.38
ROE: -27.82 2.43 16.07

BRIEF-Vical Reports Q1 Loss Per Share $0.29

* VICAL REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS

03 May 2018

BRIEF-Vical Reports Q4 Loss Per Share Of $0.21

* VICAL REPORTS FOURTH QUARTER 2017 FINANCIAL AND OPERATIONAL RESULTS

15 Mar 2018

BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs

* VICAL ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON HSV-2 AND ANTIFUNGAL CLINICAL PROGRAMS

30 Jan 2018

BUZZ-Vical: Falls as herpes vaccine fails late-stage trial

** Drugmaker's shares fall 27.81 pct to $1.35 - top pct loser among Nasdaq-listed stocks premarket

22 Jan 2018

Competitors

  Price Chg
Sanofi SA (SASY.PA) €66.23 -0.14
Novartis AG (NOVN.S) CHF76.16 -0.52
GlaxoSmithKline plc (GSK.L) 1,507.60 -1.60
AstraZeneca plc (AZN.L) 5,454.00 0.00
Merck & Co., Inc. (MRK.N) $59.17 +0.72
Pfizer Inc. (PFE.N) $35.97 +0.25
Roche Holding Ltd. (ROG.S) CHF219.25 -4.65
Roche Holding Ltd. (RO.S) CHF223.40 -5.40
Genocea Biosciences Inc (GNCA.OQ) $0.99 +0.03
Agenus Inc (AGEN.OQ) $3.48 0.00

Earnings vs. Estimates